The importance of examining an active immune system during immunotherapy
Oncotarget
.
2019 Jan 15;10(5):559-560.
doi: 10.18632/oncotarget.26580.
Authors
Heather M Gibson
1
2
,
Nerissa T Viola
1
2
Affiliations
1
Heather M. Gibson: Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA.
2
Nerissa T. Viola: Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA.
PMID:
30728906
PMCID:
PMC6355172
DOI:
10.18632/oncotarget.26580
No abstract available
Keywords:
PET; immunotherapy; interferon-γ.
Publication types
Editorial
Grants and funding
R37 CA220482/CA/NCI NIH HHS/United States